Cargando…
Might radiation therapy in addition to chemotherapy improve overall survival of patients with non-oligometastatic Stage IV non-small cell lung cancer?: Secondary analysis of two prospective studies
BACKGROUND: The role of radiation therapy in addition to chemotherapy has not been well established in non-oligometastatic Stage IV non-small cell lung cancer (NSCLC). We aimed to investigate overall survival (OS) of non-oligometastatic Stage IV NSCLC treated with chemotherapy with concurrent radiat...
Autores principales: | Su, ShengFa, Hu, YinXiang, Ouyang, WeiWei, Ma, Zhu, Li, QingSong, Li, HuiQin, Wang, Yu, Wang, XiaoHu, Li, Tao, Li, JianCheng, Chen, Ming, Lu, You, Bai, YuJu, He, ZhiXu, Lu, Bing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5117544/ https://www.ncbi.nlm.nih.gov/pubmed/27871270 http://dx.doi.org/10.1186/s12885-016-2952-3 |
Ejemplares similares
-
The survival outcomes and prognosis of stage IV non-small-cell lung cancer treated with thoracic three-dimensional radiotherapy combined with chemotherapy
por: Su, ShengFa, et al.
Publicado: (2014) -
Failure pattern and radiotherapy exploration in malignant pleural effusion non-small cell lung cancer treated with targeted therapy
por: Li, Qingsong, et al.
Publicado: (2023) -
Non-Small Cell Lung Cancer with Malignant Pleural Effusion May Require Primary Tumor Radiotherapy in Addition to Drug Treatment
por: Li, Qingsong, et al.
Publicado: (2022) -
Impact of thoracic tumor radiotherapy on survival in non‐small‐cell lung cancer with malignant pleural effusion treated with targeted therapy: Propensity score matching study
por: Li, Qingsong, et al.
Publicado: (2023) -
Reasonable Timing of Radiotherapy for Stage IV Non-Small-Cell Lung Cancer During Targeted Therapy Based on Tumour Volume Change
por: Li, Qingsong, et al.
Publicado: (2021)